NASAL ADMINISTRATION OF MORPHINE-6-GLUCURONIDE IN SHEEP - A PHARMACOKINETIC STUDY

Citation
L. Illum et al., NASAL ADMINISTRATION OF MORPHINE-6-GLUCURONIDE IN SHEEP - A PHARMACOKINETIC STUDY, Biopharmaceutics & drug disposition, 17(8), 1996, pp. 717-724
Citations number
24
Categorie Soggetti
Pharmacology & Pharmacy",Biology
ISSN journal
01422782
Volume
17
Issue
8
Year of publication
1996
Pages
717 - 724
Database
ISI
SICI code
0142-2782(1996)17:8<717:NAOMIS>2.0.ZU;2-B
Abstract
The pharmacokinetics of morphine-6-glucuronide (M6G) after both intrav enous dosing and nasal administration were studied in sheep. The nasal formulation consisted of M6G in combination with an absorption promot ing delivery system in the form of chitosan. The mean half-life of M6G after intravenous administration was 51.0 +/- 8.2 min and that after intranasal dosing was 45.0 +/- 5.5 min. M6G clearance and volume of di stribution were 5.4 +/- 1.5 mL min(-1)kg(-1) and 0.4 +/- 0.1 L kg(-1) respectively. The plasma profile after nasal administration demonstrat ed rapid absorption of M6G. The bioavailability of M6G in the chitosan formulation was found to be 31.4%. These results suggest that M6G adm inistered in combination with the chitosan delivery system may be cons idered as a suitable non-parenteral means of administering this analge sic.